Watch EIKN. Know when insiders buy.
One email the day a filing lands. Free.
EIKN
Eikon Therapeutics, Inc.
10.71
−0.15 −1.38%
USD · close Sep 8
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
86
PASS · insiders 79, shorts 92
Insiders, 90 days
+$1M
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 8.36 – 16.26
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$93.4M | −$88.4M | — | -1.63 | −$65M | $251K | −$65.2M | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$87.3M | −$83M | — | -2.46 | −$89.8M | $262K | −$90.1M | Aug 13 |
| Q2 2025 · Jun 30 | — | — | — | −$109.6M | −$105.2M | — | -36.94 | −$32.7M | $21.7M | −$54.5M | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$71.4M | −$68.2M | — | -26.91 | −$54.5M | $22.4M | −$76.9M | Aug 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|
Every number comes from Eikon Therapeutics, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.